FourThought Financial Partners, LLC

Position in ABBV — AbbVie Inc.

CIK 1956790 VENICE, FL

Position in ABBV

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$4,285,932

+$669,509 QoQ

Shares Held

17,032

+2.4% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.39%

of 13F equity value

Holder Rank

#1,414

of 4,153 holders

Holding Since

Dec 2022

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

FourThought Financial Partners, LLC holds $48,924,367 across 10 Drug Manufacturers - General names. ABBV ranks #5 (8.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AZN	Astrazeneca PLC	80,917	$15,343,481
2	AMGN	Amgen Inc	32,361	$11,718,565
3	LLY	ELI LILLY & Co	5,899	$7,075,438
4	NVO	Novo Nordisk A S	102,109	$4,895,105
5	ABBV	AbbVie Inc. This page	17,032	$4,285,932
6	JNJ	Johnson & Johnson	14,967	$3,801,168
7	MRK	Merck & Co., Inc.	4,550	$584,675
8	GILD	Gilead Sciences, Inc.	3,418	$431,830

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,285,932	17,032	+2.4%	Shares	Sole	2026-08-12
2026-03-31	$3,616,423	16,628	-3.5%	Shares	Sole	2026-05-07
2025-12-31	$3,939,167	17,240	+1.3%	Shares	Sole	2026-02-06
2025-09-30	$3,941,968	17,025	-1.6%	Shares	Sole	2025-11-13
2025-06-30	$3,212,339	17,306	-3.0%	Shares	Sole	2025-08-12
2025-03-31	$3,737,208	17,837	-1.0%	Shares	Sole	2025-05-07
2024-12-31	$3,202,331	18,021	-1.0%	Shares	Sole	2025-02-04
2024-03-31	$3,315,130	18,205	-0.2%	Shares	Sole	2024-05-14
2023-12-31	$2,828,202	18,250	+0.2%	Shares	Sole	2024-02-13
2023-09-30	$2,715,426	18,217	+4.6%	Shares	Sole	2023-11-13
2023-06-30	$2,346,322	17,415	-2.1%	Shares	Sole	2023-08-11
2023-03-31	$2,835,989	17,795	+0.2%	Shares	Sole	2023-05-04
2022-12-31	$2,871,001	17,765	—	Shares	Sole	2023-02-07
No filing history on record for this holder in this stock.